CN Patent

CN109867626A — 一种甲磺酸仑伐替尼多晶型物及其制备方法

Assigned to Jiangsu Creation Pharmaceutical Co Ltd · Expires 2019-06-11 · 7y expired

What this patent protects

本发明涉及一种甲磺酸仑伐替尼多晶型物及其制备方法。具体地，本发明提供了甲磺酸仑伐替尼二甲基亚砜溶剂化物的新晶型及其制备方法，且本发明的新晶型具有优异的晶型和化学稳定性，以及更好的流动性。

USPTO Abstract

本发明涉及一种甲磺酸仑伐替尼多晶型物及其制备方法。具体地，本发明提供了甲磺酸仑伐替尼二甲基亚砜溶剂化物的新晶型及其制备方法，且本发明的新晶型具有优异的晶型和化学稳定性，以及更好的流动性。

Drugs covered by this patent

Patent Metadata

Patent number
CN109867626A
Jurisdiction
CN
Classification
—
Expires
2019-06-11
Drug substance claim
No
Drug product claim
No
Assignee
Jiangsu Creation Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.